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A B S T R A C T
We describe here a rare case of septic pseudarthrosis due to Erysipelatoclostridium ramosum in a female
young patient. The patient, currently in remission from Ewing’s sarcoma treated by a bone resection and
allograft combined with chemotherapy, suffered from a chronic femoral pseudarthrosis in a context of
bone insufﬁciency and graft resorption. A broad range 16S PCR followed by sequencing, as well as an
enrichment culture of a bone biopsy revealed the presence of E. ramosum, an anaerobic ﬁrmicute with a
low Gram-positive afﬁnity staining and low GC content, that was further characterized by whole genome
sequencing (WGS).
© 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Erysipelatoclostridium ramosum is a Gram-positive anaerobic
enteric bacterium that is part of the normal human gut microbiota.
Originally named Bacillus ramosum (Forrester Joseph and Spain
David, 2014; Yutin and Galperin, 2013), and then most widely
known as Clostridium ramosum, this species has been renamed as
Erysipelatoclostridium ramosum in 2013 (Yutin and Galperin, 2013).
The Erysipelatoclostridium genus belongs to the new family
Erysipelatoclostridiaceae with other members of the XVIII clostrid-
ial cluster (Yutin and Galperin, 2013) and was recently conﬁrmed
as a monophyletic group in a standardized revision of the
taxonomy (Parks et al., 2018).
E. ramosum infections are rare and were mostly reported in
young patients (<5 y.o.) suffering from inner ear infections or in
immunocompromised elderly people (Forrester Joseph and Spain
David, 2014; Dahya et al., 2015). Clinical presentations encompass* Corresponding author at: Institute of Microbiology, Rue du Bugnon 48, 1011
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).a variety of cases: gas gangrene, pseudomembranous colitis, acute
otitis media, non-autoimmune hemolytic anemia, pyelonephritis,
brain or lung abscess, peritonitis, spondylodiscitis, osteomyelitis,
arthritis, bacteremia and septicemia (Dahya et al., 2015; Lavigne
et al., 2003; Alcalde-Vargas et al., 2012; García-Jiménez et al., 2016;
van der Vorm et al., 1999; Gerber et al., 2018; Mohandas et al.,
2001; Al-kali et al., 2008).
Bone infection was ﬁrst reported in 2001, for a 91-year-old
diabetic woman with a history of hypertension (Mohandas et al.,
2001). The ﬁrst case of spondylodiscitis due to E. ramosum in an
elderly immunocompetent patient without a speciﬁc history of
bone infections was reported in 2003 (Lavigne et al., 2003).
Recently, E. ramosum was detected in a tibia of a young
immunocompetent individual after a traumatic fracture and an
amputation above knee was performed after treatment failure
(Dahya et al., 2015). Here, we present a new case of septic
pseudarthrosis due to E. ramosum in a young adult patient
presenting complications to plate osteosynthesis stabilization
following a pathological fracture. Microbiological and genomic
analyses of the E. ramosum strain isolated from a bone fragment
conﬁrmed the antibiotic susceptibility and the taxonomical
assignment of the isolate.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
168 F. Zakham et al. / International Journal of Infectious Diseases 81 (2019) 167–169Case report
A 26-year-old female patient, with a historyof metastatic Ewing’s
sarcoma treated by chemotherapy and left index amputation,
underwent a large tumor resection and allograft on the right distal
femur for recurrence in 2001. In remission since then, she presented
in 2010 a pathological fracture on the same site that was stabilized by
osteosynthesis. Two years later, a femoral pseudoarthrosis with
ruptureof distal screws was treated bya complex surgeryassociating
the change of osteosynthesis material, in presence of a demineral-
ized bone matrix, and a condylar periosteal ﬂap. Culture of bone
biopsies and sonication were sterile.
Since January 2016, the patient presented a pain at the right
distal femur in a context of recurrent bone insufﬁciency and
progressive resorption of the allograft. The patient was admitted to
the hospital in May for a replacement of the screw, the partial
removal of the allograft and reconstruction of the implant with
injectable bone cement. Although the ﬁrst culture was sterile, the
strain was recovered after 5 days by culture from bone and allograft
biopsies following a 2-day enrichment in thioglycollate medium
and subculture on Schaedler blood agar incubated in anaerobic
conditions, a standard operating procedure for bone biopsies in our
laboratory. The strain was identiﬁed by MALDI-TOF (Croxatto et al.,
2012) as C. ramosum (reclassiﬁed as E. ramosum). PCR ampliﬁca-
tion of the 16S rRNA conﬁrmed the identiﬁcation of E. ramosum in
one of the peroperative bone biopsies. Antibiotic susceptibilityFigure 1. Phylogeny of the order Erysipelotrichales and frequency of E. ramosum ident
(A) The maximum likelihood tree, based on the alignment of 146 core genes, divided the 
and Erysipelatoclostridiaceae. E. ramosum strain CHUV1985 (highlighted in red) clusters
Erysipelatoclostridium. The genomes of Bacillus subtilis and Turicibacter sanguinis were us
clinical microbiology laboratory of the University Hospital of Lausanne. Over 20 years, on
from prosthetic material.testing performed according to EUCAST guidelines revealed that
the microorganism was susceptible to clindamycin. Oral clinda-
mycin (600 mg 3x/d) was prescribed and the patient was
discharged. After six weeks, a new bone allograft was performed
after the ablation of the spacer. The antibiotic initially planned for
at least one year was stopped in October 2016 after 8-month
treatment because of gastrointestinal side effects. Two years later,
the patient presents no recurrence of femoral pain.
Bacterial genomics
Genomic DNA was extracted with the Wizard Genomic DNA
Puriﬁcation kit (Promega, USA), libraries were prepared using Nextera
XT (Illumina, San Diego, USA) and sequencing was performed on a
MiSeq sequencer (Illumina). Raw sequence data was trimmed by
Trimmomatic v0.36 (parameters: SLIDINGWINDOW:5:20, LEAD-
ING:28, TRAILING:28, MINLEN:50), assembled by SPAdes v3.11.1, and
contigs larger than 500 bp harboring over 5-fold mean coverage were
annotated using PROKKA v1.13. The draft genome of E. ramosum strain
CHUV1985 comprises 3,458,191 bp and exhibits a G + C content of
33%. The strain was predicted to encode 3259 genes, 7 rRNAS, 56
tRNAs and one tmRNA. One representative genome for each 32
species of the order Erysipelotrichales as well as all E. ramosum
genomes available in NCBI’s RefSeq as of October 2018 (Supple-
mentary Table S1) were used to reconstruct groups of orthologous
proteins (orthogroups) using OrthoFinder 2.0.2. Bacillus subtilis andiﬁcation.
order Erysipelotrichales into two clades corresponding to families Erysipelotrichaceae
 with other E. ramosum strains, hence forming a monophyletic clade in the genus
ed here as outgroups. (B) E. ramosum strains were only infrequently isolated in the
ly 3 isolates were obtained from bones and one isolate, reported in this manuscript,
F. Zakham et al. / International Journal of Infectious Diseases 81 (2019) 167–169 169Turicibacter sanguinis which are other members of the Firmicutes
were used as an outgroup. The protein sequences of the 146
orthogroups present as single copy in each genome were aligned
with MAFFT v7.310 and concatenated to construct a maximum-
likelihood phylogeny with Fasttree 2.1.9, double precision. The
phylogenetic reconstruction clustered CHUV1985 with other E.
ramosum strains (Figure 1A). In agreement with the recent revision
of the bacterial taxonomy (Parks et al., 2018), the branch supporting
all Erysipelatoclostridium species was monophyletic, which con-
ﬁrmed the common ancestry of these species and supported their
classiﬁcation in the same genus. The average nucleotide identity
(ANIb), calculated with pyani v0.2.7 between E. ramosum strain
CHUV1985 and the 9 other strains of the same species was higher
than 99% (Supplementary Table S2), thereby corroborating its
taxonomic afﬁliation. References to all bioinformatics tools used for
this analysis are available in the supplementary material.
Discussion
The isolation of E. ramosum from a bone and tissue fragment of
this young patient suggested the presence of a chronic infection at
the site of bone resection and graft, likely negatively impacting
bone regeneration at the site of the allograft. While allografts are a
known source of infectious complications and non-fusion with the
adjacent bone, the patient's graft suffered a massive resorption
within 18 months, after several years of stability. No blood culture
was documented positive to E. ramosum for this patient in the past
years. Hence, we can only speculate whether the infection was
blood-borne, but remained undetected, or linked to surgery.
Infections to E. ramosum are generally rare, with only 106 cases
diagnosed in the University Hospital of Lausanne since 1997
(Figure 1B). Most E. ramosum isolates were obtained from blood
culture, and E. ramosum was isolated from bones in only three cases
(2.8%) and from prosthetic material in a single case reported here
(0.9%). To our knowledge, this is the ﬁrst case of E. ramosum
infection after an orthopedic procedure with an allograft.
16S-targeted PCR and sequencing could rapidly conﬁrm the
etiologic agent of the infectionthat had been ﬁrst isolated by
enrichment and culture in anaerobic conditions. Therefore, the use
of both molecular diagnostic and enrichment media is recom-
mended in case of culture-negative osteomyelitis. Genomic
analyses enabled to conﬁrm the taxonomic classiﬁcation of the
strain and the monophyly of the newly formed Erysipelatoclostri-
dium genus. Rapid whole genome sequencing can be used
routinely to support classic microbiology diagnostic methods such
as culture or molecular diagnostics by PCR in case of rare infections
or dubious taxonomic afﬁliations.
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